|

YSCH-01 Clinical Trials

2 actively recruiting trials

▲ +1 trial since August 2026

Pipeline

Early 1: 2

Top Sponsors

  • Huashan Hospital1
  • Cancer Institute and Hospital, Chinese Academy of Medical Sciences1

Indications

Other2 trials

Evaluating Safety, Tolerability, and Preliminary Efficacy of YSCH-01 Monotherapy and in Combination With Atezolizumab for Recurrent Glioblastoma
Early 1
YSCH-01 Via Nebulization in Pulmonary Metastasis of Advanced Solid Tumors and Non-small Cell Lung Cancer (NSCLC)
Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.